Teva Pharmaceutical Industries Investor Relations Material
Latest events
Q1 2025
Teva Pharmaceutical Industries
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Teva Pharmaceutical Industries Limited
Access all reports
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates in two segments, Generic Medicines and Specialty Medicines. The company offers various APIs and molecules for the treatment of various disorders in a range of therapeutic areas, including CNS, oncology, respiratory, cardiology and other specialty areas. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Key slides for Teva Pharmaceutical Industries Limited
Q1 2025
Teva Pharmaceutical Industries Limited
Q1 2025
Teva Pharmaceutical Industries Limited
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
TEVA
Country
🇺🇸 United States